Waddell & Reed Financial’s Axogen AXGN Stock Holding History

Waddell & Reed Financial’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-215,288	Closed	-$4.53M	–	483
2019 Q1	$4.53M	Hold	215,288	–	–	0.01%	459
2018 Q4	$4.4M	Hold	215,288	–	–	0.01%	453
2018 Q3	$7.93M	Buy	215,288 +4,100	+2%	+$179K	0.02%	453
2018 Q2	$10.6M	Sell	211,188 -24,900	-11%	-$1.1M	0.02%	405
2018 Q1	$8.62M	Sell	236,088 -74,400	-24%	-$2.28M	0.02%	438
2017 Q4	$8.79M	Sell	310,488 -12,500	-4%	-$295K	0.02%	443
2017 Q3	$6.25M	Buy	322,988 +6,900	+2%	+$116K	0.01%	454
2017 Q2	$5.29M	Sell	316,088 -33,200	-10%	-$448K	0.01%	481
2017 Q1	$3.65M	Hold	349,288	–	–	0.01%	494
2016 Q4	$3.14M	Buy	349,288 +150,000	+75%	+$1.29M	0.01%	530
2016 Q3	$1.8M	Hold	199,288	–	–	﹤0.01%	567
2016 Q2	$1.37M	Buy	+199,288	New	+$1.13M	﹤0.01%	569

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Waddell & Reed Financial's AXGN Position: Q2 2019 in Review

Waddell & Reed Financial sold out of Axogen (AXGN) in Q2 2019, closing a stake of 215,288 shares — an estimated $4.53M sold.

Waddell & Reed Financial first reported a position in AXGN in Q2 2016 and held it in 12 quarters. The position peaked at $10.6M in Q2 2018. 134 funds tracked by Wall St. Rank hold AXGN as of Q2 2019.

Waddell & Reed Financial reported no remaining Axogen position as of Q2 2019 after selling out during the quarter.
Waddell & Reed Financial sold 215,288 Axogen shares in Q2 2019, an estimated $4.53M.
Waddell & Reed Financial first reported a position in Axogen in Q2 2016 and held it in 12 quarters.
Waddell & Reed Financial's Axogen position peaked at $10.6M in Q2 2018.
134 funds tracked by Wall St. Rank held Axogen as of Q2 2019.

Based on Waddell & Reed Financial's 13F filing for Q2 2019, filed 14 Aug 2019.